Takeda Pharmaceutical Company Limited (4502.T)
JPY 4419.0
(1.08%)
JPY 4419.0
(1.08%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 7834.78 Billion JPY | 3.05% |
| 2022 | 7603.07 Billion JPY | 1.45% |
| 2021 | 7494.49 Billion JPY | -3.11% |
| 2020 | 7735.11 Billion JPY | -4.43% |
| 2019 | 8093.6 Billion JPY | -7.06% |
| 2018 | 8708.73 Billion JPY | 316.87% |
| 2017 | 2089.05 Billion JPY | -13.2% |
| 2016 | 2406.81 Billion JPY | 32.76% |
| 2015 | 1812.88 Billion JPY | -13.26% |
| 2014 | 2090.01 Billion JPY | 3.03% |
| 2013 | 2028.5 Billion JPY | 17.1% |
| 2012 | 1732.24 Billion JPY | 15.09% |
| 2011 | 1505.16 Billion JPY | 131.65% |
| 2010 | 649.74 Billion JPY | -1.33% |
| 2009 | 658.52 Billion JPY | -6.77% |
| 2008 | 706.34 Billion JPY | 34.1% |
| 2007 | 526.74 Billion JPY | -13.84% |
| 2006 | 611.38 Billion JPY | -11.89% |
| 2005 | 693.86 Billion JPY | 27.54% |
| 2004 | 544.02 Billion JPY | -1.92% |
| 2003 | 554.65 Billion JPY | 12.82% |
| 2002 | 491.63 Billion JPY | -2.82% |
| 2001 | 505.88 Billion JPY | 1.65% |
| 2000 | 497.69 Billion JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 8428.45 Billion JPY | 7.58% |
| 2024 Q2 | 7651.4 Billion JPY | -9.22% |
| 2023 Q1 | 7871.06 Billion JPY | 3.52% |
| 2023 Q4 | 7834.78 Billion JPY | 4.74% |
| 2023 Q2 | 7800.86 Billion JPY | -0.89% |
| 2023 Q3 | 7480.34 Billion JPY | -4.11% |
| 2023 FY | 7834.78 Billion JPY | 3.05% |
| 2022 Q1 | 7748.04 Billion JPY | 3.38% |
| 2022 Q4 | 7603.07 Billion JPY | 3.75% |
| 2022 Q3 | 7328.2 Billion JPY | -6.95% |
| 2022 Q2 | 7875.35 Billion JPY | 1.64% |
| 2022 FY | 7603.07 Billion JPY | 1.45% |
| 2021 Q4 | 7494.49 Billion JPY | 1.73% |
| 2021 Q2 | 7235.91 Billion JPY | -2.46% |
| 2021 Q1 | 7418.59 Billion JPY | -4.09% |
| 2021 FY | 7494.49 Billion JPY | -3.11% |
| 2021 Q3 | 7366.69 Billion JPY | 1.81% |
| 2020 FY | 7735.11 Billion JPY | -4.43% |
| 2020 Q1 | 7923.08 Billion JPY | -2.11% |
| 2020 Q2 | 7748.24 Billion JPY | -2.21% |
| 2020 Q3 | 7646.7 Billion JPY | -1.31% |
| 2020 Q4 | 7735.11 Billion JPY | 1.16% |
| 2019 FY | 8093.6 Billion JPY | -7.06% |
| 2019 Q3 | 8155.27 Billion JPY | 1.81% |
| 2019 Q2 | 8010.45 Billion JPY | -7.67% |
| 2019 Q1 | 8675.97 Billion JPY | -0.38% |
| 2019 Q4 | 8093.6 Billion JPY | -0.76% |
| 2018 Q4 | 8708.73 Billion JPY | 133.81% |
| 2018 Q3 | 3724.64 Billion JPY | 77.14% |
| 2018 Q2 | 2102.67 Billion JPY | 0.46% |
| 2018 Q1 | 2093 Billion JPY | 0.19% |
| 2018 FY | 8708.73 Billion JPY | 316.87% |
| 2017 Q1 | 2309.13 Billion JPY | -4.06% |
| 2017 FY | 2089.05 Billion JPY | -13.2% |
| 2017 Q4 | 2089.05 Billion JPY | -8.23% |
| 2017 Q3 | 2276.47 Billion JPY | 0.27% |
| 2017 Q2 | 2270.25 Billion JPY | -1.68% |
| 2016 Q2 | 1922.77 Billion JPY | -1.28% |
| 2016 Q4 | 2406.81 Billion JPY | 14.74% |
| 2016 Q3 | 2097.62 Billion JPY | 9.09% |
| 2016 Q1 | 1947.72 Billion JPY | 7.44% |
| 2016 FY | 2406.81 Billion JPY | 32.76% |
| 2015 FY | 1812.88 Billion JPY | -13.26% |
| 2015 Q4 | 1812.88 Billion JPY | -10.59% |
| 2015 Q3 | 2027.5 Billion JPY | -0.2% |
| 2015 Q2 | 2031.51 Billion JPY | -2.76% |
| 2015 Q1 | 2089.22 Billion JPY | -0.04% |
| 2014 Q3 | 2080.5 Billion JPY | 1.94% |
| 2014 FY | 2090.01 Billion JPY | 3.03% |
| 2014 Q1 | 1983.33 Billion JPY | -2.23% |
| 2014 Q2 | 2040.87 Billion JPY | 2.9% |
| 2014 Q4 | 2090.01 Billion JPY | 0.46% |
| 2013 Q4 | 2028.5 Billion JPY | 2.84% |
| 2013 FY | 2028.5 Billion JPY | 17.1% |
| 2013 Q3 | 1972.54 Billion JPY | 3.49% |
| 2013 Q2 | 1906.04 Billion JPY | 15.02% |
| 2013 Q1 | 1657.19 Billion JPY | -4.33% |
| 2012 FY | 1732.24 Billion JPY | 15.09% |
| 2012 Q1 | 1517.75 Billion JPY | 0.84% |
| 2012 Q4 | 1732.24 Billion JPY | 4.27% |
| 2012 Q2 | 1510.96 Billion JPY | -0.45% |
| 2012 Q3 | 1661.31 Billion JPY | 9.95% |
| 2011 Q2 | 1454.23 Billion JPY | 143.52% |
| 2011 FY | 1505.16 Billion JPY | 131.65% |
| 2011 Q3 | 1446.5 Billion JPY | -0.53% |
| 2011 Q1 | 597.15 Billion JPY | -8.09% |
| 2011 Q4 | 1505.16 Billion JPY | 4.06% |
| 2010 Q4 | 649.74 Billion JPY | 10.59% |
| 2010 Q1 | 599.37 Billion JPY | -8.98% |
| 2010 Q2 | 595.18 Billion JPY | -0.7% |
| 2010 Q3 | 587.53 Billion JPY | -1.29% |
| 2010 FY | 649.74 Billion JPY | -1.33% |
| 2009 Q2 | 651.11 Billion JPY | 0.0% |
| 2009 FY | 658.52 Billion JPY | -6.77% |
| 2009 Q4 | 658.52 Billion JPY | 1.85% |
| 2009 Q3 | 646.57 Billion JPY | -0.7% |
| 2008 FY | 706.34 Billion JPY | 34.1% |
| 2008 Q3 | 635.81 Billion JPY | 0.0% |
| 2008 Q4 | 706.34 Billion JPY | 11.09% |
| 2007 FY | 526.74 Billion JPY | -13.84% |
| 2006 FY | 611.38 Billion JPY | -11.89% |
| 2005 FY | 693.86 Billion JPY | 27.54% |
| 2004 FY | 544.02 Billion JPY | -1.92% |
| 2003 FY | 554.65 Billion JPY | 12.82% |
| 2002 FY | 491.63 Billion JPY | -2.82% |
| 2001 FY | 505.88 Billion JPY | 1.65% |
| 2000 FY | 497.69 Billion JPY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 24.98 Billion JPY | -31254.202% |
| Sumitomo Pharma Co., Ltd. | 751.37 Billion JPY | -942.734% |
| Shionogi & Co., Ltd. | 164.35 Billion JPY | -4667.02% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.39 Billion JPY | -230675.743% |
| Nippon Shinyaku Co., Ltd. | 42.86 Billion JPY | -18176.542% |
| Kaken Pharmaceutical Co., Ltd. | 27.86 Billion JPY | -28015.941% |
| Eisai Co., Ltd. | 494.82 Billion JPY | -1483.345% |
| Morishita Jintan Co., Ltd. | 5.04 Billion JPY | -155352.143% |
| Hisamitsu Pharmaceutical Co., Inc. | 61.69 Billion JPY | -12599.433% |
| Mochida Pharmaceutical Co., Ltd. | 30.83 Billion JPY | -25311.222% |
| Fuso Pharmaceutical Industries,Ltd. | 39.79 Billion JPY | -19588.365% |
| Nippon Chemiphar Co., Ltd. | 31.08 Billion JPY | -25105.212% |
| Tsumura & Co. | 132.88 Billion JPY | -5795.872% |
| Kissei Pharmaceutical Co., Ltd. | 39.79 Billion JPY | -19589.849% |
| Torii Pharmaceutical Co., Ltd. | 13.29 Billion JPY | -58821.471% |
| Towa Pharmaceutical Co., Ltd. | 274.75 Billion JPY | -2751.523% |
| Fuji Pharma Co., Ltd. | 44.15 Billion JPY | -17642.624% |
| Zeria Pharmaceutical Co., Ltd. | 70.7 Billion JPY | -10980.985% |
| KYORIN Holdings, Inc. | 46.89 Billion JPY | -16607.799% |
| Taiko Pharmaceutical Co.,Ltd. | 7 Billion JPY | -111777.595% |
| Daito Pharmaceutical Co.,Ltd. | 25.43 Billion JPY | -30698.333% |
| SymBio Pharmaceuticals Limited | 8.14 Billion JPY | -96125.228% |
| MedRx Co., Ltd | 129 Million JPY | -6073379.07% |
| Mizuho Medy Co.,Ltd. | 3.27 Billion JPY | -239310.365% |
| Solasia Pharma K.K. | 673 Million JPY | -1164058.692% |
| Modalis Therapeutics Corporation | 645.5 Million JPY | -1213649.278% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 31.38 Billion JPY | -24866.661% |
| Sawai Group Holdings Co., Ltd. | 163.99 Billion JPY | -4677.485% |
| Cyfuse Biomedical K.K. | 1.01 Billion JPY | -774593.773% |
| Toho Holdings Co., Ltd. | 523.98 Billion JPY | -1395.226% |
| Koa Shoji Holdings Co.,Ltd. | 6.95 Billion JPY | -112592.836% |